ODDITY Tech Stock News

Many companies that have sought to adopt AI are understandably in the most tech-focused areas of the economy. However, finding ways to bring more consumer-facing applications for artificial intelligence holds great promise.

Oddity Tech is recommended as a buy, with the platform thesis now materially de-risked by MethodIQ's launch and international scaling. MethodIQ and ODDITY Labs transform ODD into a defensible technology platform, offering proprietary molecules and higher efficacy in the $27B acne and dermatology market. International revenue is growing ~40% year-to-date, validating ODD's scalable, language-agno...

Oddity combines high growth, profitability, and a data-driven advantage, differentiating it from traditional beauty brands and creating a compelling investment case. ODD leverages machine learning and direct-to-consumer models, fueling rapid revenue growth, high margins, and successful brand launches like IL MAKIAGE, SpoiledChild, and METHODIQ. After a 50% pullback, ODD trades at an attractive ...

Oddity's sales and profits are growing at an impressive clip. Management sees further gain ahead.

Oddity Tech Ltd. ( ODD ) Q3 2025 Earnings Call November 20, 2025 8:30 AM EST Company Participants Maria Lycouris Oran Holtzman - Co-Founder, CEO & Director Lindsay Mann - Global Chief Financial Officer Conference Call Participants Dara Mohsenian - Morgan Stanley, Research Division Anna Lizzul - BofA Securities, Research Division Youssef Squali - Truist Securities, Inc., Research Division Andrew...

NEW YORK, Nov. 19, 2025 (GLOBE NEWSWIRE) -- ODDITY Tech Ltd. (NASDAQ: ODD) today announced its financial results for the third quarter ended September 30, 2025.

This quarter, we re-established a position in Arista Networks, a leading provider of high-performance networking solutions for data centers, cloud providers, and enterprises. We initiated a starter position in Synopsys after shares sold off following the company's third quarter earnings report and our in-person meeting with management. We exited our CyberArk Software Ltd. position after its acq...

Oddity, the maker of Il Makiage and Spoiled Child, launched its third brand Methodiq, a telehealth platform for medical skincare. Methodiq will offer 28 new products, including creams, supplements and cosmetics, that address acne, hyperpigmentation and eczema and range in price from about $29 to around $59.